FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
fj.06-6628comv1
21/3/732    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, Y.
Right arrow Articles by van der Maarel, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, Y.
Right arrow Articles by van der Maarel, S. M.
Published online before print December 21, 2006 as doi: 10.1096/fj.06-6628com.

AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration

Yanchao Huang, Steven H. Laval, Alexandra van Remoortere, Jacques Baudier, Chriselle Benaud, Louise V. B. Anderson, Volker Straub, Andre Deelder, Rune R. Frants, Johan T. den Dunnen, Kate Bushby, and Silvère M. van der Maarel

E-mail contact: maarel@lumc.nl

Mutations in dysferlin cause limb girdle muscular dystrophy 2B, Miyoshi myopathy and distal anterior compartment myopathy. Dysferlin is proposed to play a role in muscle membrane repair. To gain functional insight into the molecular mechanisms of dysferlin, we have searched for dysferlin-interacting proteins in skeletal muscle. By coimmunoprecipitation coupled with mass spectrometry, we demonstrate that AHNAK interacts with dysferlin. We defined the binding sites in dysferlin and AHNAK as the C2A domain in dysferlin and the carboxyterminal domain of AHNAK by glutathione S-transferase (GST)-pull down assays. As expected, the N-terminal domain of myoferlin also interacts with the carboxyterminal domain of AHNAK. In normal skeletal muscle, dysferlin and AHNAK colocalize at the sarcolemmal membrane and T-tubules. In dysferlinopathies, reduction or absence of dysferlin correlates with a secondary muscle-specific loss of AHNAK. Moreover, in regenerating rat muscle, dysferlin and AHNAK showed a marked increase and cytoplasmic localization, consistent with the direct interaction between them. Our data suggest that dysferlin participates in the recruitment and stabilization of AHNAK to the sarcolemma and that AHNAK plays a role in dysferlin membrane repair process. It may also have significant implications for understanding the biology of AHNAK-containing exocytotic vesicles, "enlargosomes," in plasma membrane remodeling and repair.--Huang Y., Laval S. H., van Remoortere A., Baudier J., Benaud C., Anderson L. V. B., Straub V., Deelder A., Frants R. R., den Dunnen J. T., Bushby K., van der Maarel S. M. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
A. A. Alli and W. R. Gower Jr.
The C type natriuretic peptide receptor tethers AHNAK1 at the plasma membrane to potentiate arachidonic acid-induced calcium mobilization
Am J Physiol Cell Physiol, November 1, 2009; 297(5): C1157 - C1167.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. P. Millay, M. Maillet, J. A. Roche, M. A. Sargent, E. M. McNally, R. J. Bloch, and J. D. Molkentin
Genetic Manipulation of Dysferlin Expression in Skeletal Muscle: Novel Insights into Muscular Dystrophy
Am. J. Pathol., November 1, 2009; 175(5): 1817 - 1823.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
Y. Shao, K. J. Czymmek, P. A. Jones, V. P. Fomin, K. Akanbi, R. L. Duncan, and M. C. Farach-Carson
Dynamic interactions between L-type voltage-sensitive calcium channel Cav1.2 subunits and ahnak in osteoblastic cells
Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1067 - C1078.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E. R. Dabkowski, C. L. Williamson, V. C. Bukowski, R. S. Chapman, S. S. Leonard, C. J. Peer, P. S. Callery, and J. M. Hollander
Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations
Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H359 - H369.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
Y. Huang, A. de Morree, A. van Remoortere, K. Bushby, R. R. Frants, J. T. Dunnen, and S. M. van der Maarel
Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle
Hum. Mol. Genet., June 15, 2008; 17(12): 1855 - 1866.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. J. Hernandez-Deviez, M. T. Howes, S. H. Laval, K. Bushby, J. F. Hancock, and R. G. Parton
Caveolin Regulates Endocytosis of the Muscle Repair Protein, Dysferlin
J. Biol. Chem., March 7, 2008; 283(10): 6476 - 6488.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. H. Lee, H. J. Lim, S. Yoon, J. K. Seong, D. S. Bae, S. G. Rhee, and Y. S. Bae
Ahnak Protein Activates Protein Kinase C (PKC) through Dissociation of the PKC-Protein Phosphatase 2A Complex
J. Biol. Chem., March 7, 2008; 283(10): 6312 - 6320.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by The Federation of American Societies for Experimental Biology.